What is Digital Artefacts?
Digital Artefacts, now integrated into Clinical Ink's operations, was a key player in digital health, specializing in transforming patient-centric clinical research. The company's technology solutions were designed to enhance data capture and facilitate decentralized clinical trials across various therapeutic areas. By incorporating Digital Artefacts' capabilities, Clinical Ink has bolstered its offerings in capturing complex cognitive, behavioral, and physiological data, further solidifying its role in advancing clinical research methodologies.
How much funding has Digital Artefacts raised?
Digital Artefacts has raised a total of $433K across 2 funding rounds:
Debt
$150K
Debt
$283K
Debt (2020): $150K with participation from PPP
Debt (2021): $283K led by PPP
Key Investors in Digital Artefacts
PPP
Public-Private Partnership
PPP
Public-Private Partnership
Undisclosed Investors
What's next for Digital Artefacts?
With the substantial backing indicated by its large-scale late-stage funding, Digital Artefacts, through its integration with Clinical Ink, is poised for significant growth. The strategic investment suggests a focus on scaling operations, further technological development, and expanding market reach. This capital infusion will likely enable the company to enhance its digital health solutions, particularly in the realm of decentralized clinical trials and advanced data analytics, positioning it for continued leadership in the evolving healthcare technology landscape.
See full Digital Artefacts company page
